相关产品推荐更多 >

(R)-3-(3-甲基丁酰基)-4-苄基恶唑烷-2-一,(R)-3-(3-Methylbutanoyl)-4-benzyloxazolidin-2-one,CAS:145589-03-3
¥11
5-山梨酸异山梨酯,Isosorbide 5-Mononitrate,CAS:16051-77-7
¥11
Zileuton sodium-Zileuton sodium
¥33
乙酸麦角甾醇,Ergosterol Acetate,CAS:2418-45-3
¥11
2,2,13,13-四甲基-4,7,11-三氧代-3,12-二氧杂-5,8-二氮杂十四烷-6-羧酸,2,2,13,13-Tetramethyl-4,7,11-trioxo-3,12-dioxa-5,8-diazatetradecane-6-carboxylic Acid,CAS:1076199-43-3
¥11
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略:5 种常见类型+关键误区Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
该Recombinant Mouse IL-1 beta产品的保存方式具体查看产品。
- 保质期:
1年
- 英文名:
Recombinant Mouse IL-1 beta
- 库存:
100
- 供应商:
艾美捷科技
- CAS号:
无
- 规格:
10ug
Recombinant Mouse IL-1 beta,Recombinant Mouse IL-1 beta,Recombinant Mouse IL-1 beta,Recombinant Mouse IL-1 beta
Recombinant Mouse IL-1 beta-Recombinant Mouse IL-1 beta
产品货号:APE-P1160-01
产品规格:10ug
重组鼠白细胞介素1β

Peptides & Proteins|Recombinant Proteins

Recombinant Mouse IL-1 beta-Recombinant Mouse IL-1 beta该Recombinant Mouse IL-1 beta产品的保存方式具体查看产品。
点击:Recombinant Mouse IL-1 beta-Recombinant Mouse IL-1 beta查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多APExBIO公司特色小分子抑制剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验FA Extraction of [insoluble] Amyloid beta from Mouse Brain
plates, as a precipitate forms when samples are loaded neat. If analyzing tissue with a lot of plaques, you need larger dilution factors to analyze amyloid beta levels within the range of the standard curve. To determine amyloid beta [c] in samples
diabetic mouse model. Furthermore, the detection of peripheral autoreactive CD8+ T cells in this mouse model is indicative of beta cell killing and correlates with the development of diabetes. We describe two protocols that are helpful for the detection
Bacterial beta-Galactosidase Histochemisty Bible
This is a collection of procedures and lore associated with staining mammalian tissue for bacterial beta-galactosidase. Unfortunately, I can't attribute much of the development work, since I was generally given protocols second or third-hand. I've
技术资料暂无技术资料 索取技术资料







